Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genome Explorations
Memphis, Tennessee, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Genome Explorations operates CLIA-certified, GLP-compliant laboratories that use next-generation sequencing and microarray platforms to deliver clinical molecular diagnostics and genomic profiling services, including cancer MDx panels, prenatal screening, pharmacogenomics, and panels for cardiovascular and hereditary disorders, supporting biomarker discovery, companion diagnostics development, and clinical validation programs.[1][2][3][4]
- Therapeutic areas
- OtherWomen's HealthCardiovascularRare DiseasesOncology
- Modalities
- Diagnostic testGenomic profilingMolecular diagnostics
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on Genome Explorations.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genome Explorations.